About Baxter International, Inc.

Baxter International, Inc. provides portfolio of essential renal and hospital products, including acute and chronic dialysis, sterile IV solutions, infusion systems and devices, parenteral nutrition therapies; premixed and oncolytic injectable, bio surgery products and anesthetics, drug reconstitution systems; and pharmacy automation, software and services. It operates through the following segment: Americas, Europe, Middle East & Africa and Asia-Pacific. The company was founded by Davis Baxter in 1931 and is headquartered in Deerfield, IL.

At the moment the company generates 11080M USD in revenues.

On its last earning announcement, the company reported a profit of 2.97$ per share.

The book value per share is 16.62$

Baxter International, Inc. website


Financials

Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
11080M 42.10% 1522M 13.70% 1582M 2.97 0.79 40.29% 532M 16.62 1855M -722M 1133M